Dreamm-5: Platform Trial Evaluating Belantamab Mafodotin (A Bcma-Directed Immuno-Conjugate) In Combination With Novel Agents In Relapsed Or Refractory Multiple Myeloma (Rrmm)

BLOOD(2019)

引用 8|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要